Buehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, 420 E. Superior St., Chicago, IL, 60611, USA.
Smith Child Health Research, Outreach and Advocacy Center, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave., Chicago, IL, 60611, USA.
BMC Public Health. 2021 Apr 21;21(1):767. doi: 10.1186/s12889-021-10792-y.
To examine prevalence, demographic, and incident factors associated with opioid-positivity in Illinois suicide decedents who died by causes other than poisoning.
Cross-sectional study of Illinois' suicide decedents occurring between January 2015 and December 2017. Data come from the National Violent Death Reporting System. We used Chi-square tests to compare decedent and incident circumstance characteristics by opioid toxicology screen status. Incident narratives were analyzed to obtain physical and mental health histories and circumstances related to fatal injury events.
Of 1007 non-poisoning suicide decedents screened for opioids, 16.4% were opioid-positive. White race, age 75 and over, and widowed or unknown marital status were associated with opioid-positivity. Among opioid-positive decedents, 25% had a history of substance use disorder (SUD), 61% depression, and 19% anxiety. The majority (52%) of opioid-positive decedents died by firearm, a higher percentage than opioid-negative decedents.
The opioid overdose crisis largely has not overlapped with non-poisoning suicide in this study. Overall, our analyses have not identified additional risk factors for suicide among opioid-positive suicide decedents. However, the overlap between opioid-positivity, SUD, and physical and mental health problems found among decedents in our data suggest several suicide prevention opportunities. These include medication assisted treatment for SUD which has been shown to reduce suicide, screening for opioid/benzodiazepine overlap, and limiting access to lethal means during opioid use. Improved death scene investigations for substances and use of the Prescription Drug Monitoring Program to document prescriptions are needed to further understanding of the role of substances in non-poisoning suicide.
调查伊利诺伊州非中毒自杀死亡者中与阿片类药物阳性相关的流行率、人口统计学和发病因素。
这是一项横断面研究,研究对象为 2015 年 1 月至 2017 年 12 月期间伊利诺伊州的自杀死亡者。数据来自国家暴力死亡报告系统。我们使用卡方检验比较了阿片类药物毒理学筛查结果不同的死者和发病情况特征。对发病情况进行了分析,以获取与致命伤害事件相关的身体和心理健康史及情况。
在 1007 名接受阿片类药物筛查的非中毒自杀死亡者中,16.4%为阿片类药物阳性。白人种族、75 岁及以上年龄以及丧偶或婚姻状况不明与阿片类药物阳性有关。在阿片类药物阳性死亡者中,25%有物质使用障碍史,61%有抑郁史,19%有焦虑史。大多数(52%)阿片类药物阳性死亡者死于枪支,这一比例高于阿片类药物阴性死亡者。
在这项研究中,阿片类药物过量危机在很大程度上并未与非中毒自杀重叠。总的来说,我们的分析并未确定阿片类药物阳性自杀死亡者自杀的其他风险因素。然而,我们的数据中发现的阿片类药物阳性、物质使用障碍以及身体和心理健康问题之间的重叠表明存在一些预防自杀的机会。这些机会包括针对物质使用障碍的药物辅助治疗,该治疗已被证明可以降低自杀率,筛查阿片类药物/苯二氮䓬类药物重叠情况,以及在阿片类药物使用期间限制获得致命手段的机会。需要进一步改进对物质的死亡现场调查,并使用处方药物监测计划记录处方,以进一步了解物质在非中毒自杀中的作用。